Background The incidence of melanoma in Australia continues to rise. Early diagnosis and management before the melanoma has metastasised provides the best opportunity for a favourable outcome. Objective This article discusses the management of melanoma once a clinical diagnosis has been made. Discussion If melanoma is suspected, initial excision biopsy is recommended. Wide excision margins are then based on reported tumour thickness. Sentinel lymph node biopsy provides important prognostic information and a probable survival benefit for patients with intermediate thickness melanomas. Other staging tests are not indicated in patients with clinically localised primary melanomas. Complete lymph node dissection is required if microscopic or mac...
This article reviews the epidemiology, diagnosis and treatment of cutaneous melanoma, including the ...
The guidelines 'Melanoma' (3rd revision) are evidence-based in nature. A number of outcomes are summ...
Over a 60-year period, the Sydney Melanoma Unit, which became Melanoma Institute Australia (MIA) in ...
melanoma is the fourth most commonly diagnosed malignancy in Australia. Nodular melanoma (NM) compri...
INTRODUCTION: The evidence-based national clinical practice guidelines for the management of cutaneo...
Objective.1. The Guideline for the Management of Melanoma has been developed in an attempt to improv...
In Australia, there is a high incidence of melanoma, and until recently, the treatment and median ov...
Introduction: Definitive management of primary cutaneous melanoma consists of surgical excision of t...
In 2002 reporting of melanoma to cancer registries in Australia and New Zealand revealed it to be th...
BACKGROUND/OBJECTIVES: To describe the method of diagnosis, clinical management and adherence to cli...
Background and objectives In Australia, the uptake of the sentinel lymph node biopsy (SLNB) appea...
IntroductionSentinel lymph node biopsy (SLNB) is a diagnostic procedure developed in the 1990s. It i...
AbstractMelanoma is a common cutaneous tumour. It is of great importance due to its increasing incid...
A diagnosis of metastaƟ c melanoma confers a poor prognosis, with a median overall survival of six t...
Melanoma is skin tumor with higher malignity. Malignityi of melanocites occurs not only in the epith...
This article reviews the epidemiology, diagnosis and treatment of cutaneous melanoma, including the ...
The guidelines 'Melanoma' (3rd revision) are evidence-based in nature. A number of outcomes are summ...
Over a 60-year period, the Sydney Melanoma Unit, which became Melanoma Institute Australia (MIA) in ...
melanoma is the fourth most commonly diagnosed malignancy in Australia. Nodular melanoma (NM) compri...
INTRODUCTION: The evidence-based national clinical practice guidelines for the management of cutaneo...
Objective.1. The Guideline for the Management of Melanoma has been developed in an attempt to improv...
In Australia, there is a high incidence of melanoma, and until recently, the treatment and median ov...
Introduction: Definitive management of primary cutaneous melanoma consists of surgical excision of t...
In 2002 reporting of melanoma to cancer registries in Australia and New Zealand revealed it to be th...
BACKGROUND/OBJECTIVES: To describe the method of diagnosis, clinical management and adherence to cli...
Background and objectives In Australia, the uptake of the sentinel lymph node biopsy (SLNB) appea...
IntroductionSentinel lymph node biopsy (SLNB) is a diagnostic procedure developed in the 1990s. It i...
AbstractMelanoma is a common cutaneous tumour. It is of great importance due to its increasing incid...
A diagnosis of metastaƟ c melanoma confers a poor prognosis, with a median overall survival of six t...
Melanoma is skin tumor with higher malignity. Malignityi of melanocites occurs not only in the epith...
This article reviews the epidemiology, diagnosis and treatment of cutaneous melanoma, including the ...
The guidelines 'Melanoma' (3rd revision) are evidence-based in nature. A number of outcomes are summ...
Over a 60-year period, the Sydney Melanoma Unit, which became Melanoma Institute Australia (MIA) in ...